BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
-4.06%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$128M
AUM Growth
+$128M
(-9.8%)
Cap. Flow
-$2.3M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
76.57%
Holding
60
New
3
Increased
5
Reduced
1
Closed
5
Top Buys
| 1 |
Travere Therapeutics
TVTX
|
$675K |
| 2 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$347K |
| 3 |
BLUE
bluebird bio
BLUE
|
$322K |
| 4 |
Progyny
PGNY
|
$289K |
| 5 |
Elutia
ELUT
|
$211K |
Top Sells
Sector Composition
| 1 | Healthcare | 96.37% |
| 2 | Energy | 3.59% |
| 3 | Consumer Staples | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $50.5M | 39.54% |
728,585
+800
| +0.1% | +$55.4K |
|
2
Biodesix
BDSX
$62.6M
| $9.37M | 7.34% |
5,039,633
| – | – |
|
3
Neurocrine Biosciences
NBIX
$13.8B
| $8.53M | 6.68% |
84,240
| – | – |
|
4
Prothena Corp
PRTA
$441M
| $6.22M | 4.87% |
128,395
+1,200
| +0.9% | +$58.2K |
|
5
QuidelOrtho
QDEL
$1.95B
| $5.46M | 4.28% |
61,306
| – | – |
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.69M | 3.68% |
249,400
| – | – |
|
7
Harrow
HROW
$1.44B
| $3.81M | 2.98% |
180,000
| – | – |
|
8
United Therapeutics
UTHR
$13.8B
| $3.36M | 2.63% |
15,000
| – | – |
|
9
Ovintiv
OVV
$10.8B
| $3.04M | 2.38% |
84,200
| – | – |
|
10
Masimo
MASI
$7.59B
| $2.82M | 2.21% |
15,280
| – | – |
|
11
Phreesia
PHR
$1.88B
| $2.67M | 2.09% |
82,700
| – | – |
|
|
12
Elutia
ELUT
$96.7M
| $2.5M | 1.96% |
1,655,184
+140,000
| +9% | +$211K |
|
13
Foghorn Therapeutics
FHTX
$286M
| $1.64M | 1.29% |
264,843
| – | – |
|
|
AXDX
14
DELISTED
Accelerate Diagnostics
AXDX
| $1.58M | 1.23% |
2,252,388
| – | – |
|
15
Alkermes
ALKS
$4.78B
| $1.41M | 1.1% |
50,000
| – | – |
|
|
INBX
16
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $1.33M | 1.04% |
70,448
| – | – |
|
17
Alphatec Holdings
ATEC
$2.35B
| $1.25M | 0.98% |
80,000
-10,000
| -11% | -$156K |
|
18
Karyopharm Therapeutics
KPTI
$61.7M
| $1.13M | 0.89% |
291,332
| – | – |
|
19
Corcept Therapeutics
CORT
$7.35B
| $1.08M | 0.85% |
50,000
| – | – |
|
20
DocGo
DCGO
$153M
| $952K | 0.75% |
110,000
| – | – |
|
21
Ventyx Biosciences
VTYX
$171M
| $884K | 0.69% |
26,400
+4,400
| +20% | +$147K |
|
22
Cytokinetics
CYTK
$4.23B
| $880K | 0.69% |
25,000
| – | – |
|
23
Protagonist Therapeutics
PTGX
$3.67B
| $874K | 0.68% |
38,000
| – | – |
|
24
Apellis Pharmaceuticals
APLS
$3.48B
| $792K | 0.62% |
12,000
| – | – |
|
|
PXD
25
DELISTED
Pioneer Natural Resource Co.
PXD
| $776K | 0.61% |
3,800
| – | – |
|